We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Exhaled Breath Test Discriminates COPD

By LabMedica International staff writers
Posted on 28 Jun 2017
Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term poor airflow. More...
The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time.

Analysis of exhaled breath by real-time mass spectrometry helps discriminate between patients with chronic obstructive pulmonary disease (COPD), healthy controls, and patients with asthma. COPD is presently diagnosed based upon airflow restriction in spirometry, respiratory symptoms, and history of exposure to risk factors.

Scientists at the University Hospital Zurich (Switzerland) compared 49 patients with COPD whose mean age was 64 years 59.2% were male; 53 healthy control subjects whose mean age was 43 years and 52.8%were female, and 31 patients with asthma whose mean age was 41 years and 64.5% were male. The team used secondary electrospray ionization/high-resolution mass spectrometry to define a series of potential markers in exhaled breath with the potential to discriminate patients with COPD from healthy controls.

The team identified 57 specific COPD discriminatory markers, with a further 56 that overlapped with the control subjects, and 17 with the subjects with asthma, all 17 of which were common to all of these patients. Identification of 23 compounds using real-time mass spectrometry that best defined signals significantly correlated with forced expiratory volume in one second predicted (FEV1%-predicted) in terms of the FEV1/ forced vital capacity (FVC-predicted) ratio. These compounds generally belong to the oxidative stress cascade and the lipolysis cascade. Patients with COPD showed FEV1 44.6, FVC 75.8, and FEV1/FVC ratio of 44. The healthy control subjects showed FEV1 101.2, FVC 105.3, and FEV1/FVC ratio of 81. Patients with asthma had FEV1 84.4, FVC 99.5, and FEV1/FVC ratio of 70.

Yvonne Nussbaumer-Ochsner, MD, the lead author, said, “There are more biomarkers overlapping with the control group than with asthma, which is actually also a kind of chronic obstructive airways disorder. Asthmatics appear to have different biomarkers in their exhaled breath compared with both controls and patients with COPD.” The study was presented on June 8, 2017, at the Joint CHEST-Swiss Society of Pneumology Congress (CHEST-SGP) held in Basel, Switzerland.

Related Links:
University Hospital Zurich


New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Candida Glabrata Test
ELIchrom Glabrata
New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.